Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Gary Edward Borodic, M.D.


Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Ma L, Jakobiec FA, Wolkow N, Dryja TP, Borodic GE. Multiple Eyelid Cysts (Apocrine and Eccrine Hidrocystomas, Trichilemmal Cyst, and Hybrid Cyst) in a Patient With a Prolactinoma. Ophthalmic Plast Reconstr Surg. 2018 May/Jun; 34(3):e83-e85. PMID: 29351118.
    Citations:    Fields:    Translation:Humans
  2. Borodic GE, Caruso P, Acquadro M, Chick S. Parry-Romberg syndrome vasculopathy and its treatment with botulinum toxin. Ophthalmic Plast Reconstr Surg. 2014 Jan-Feb; 30(1):e22-5. PMID: 23719195.
    Citations: 2     Fields:    Translation:Humans
  3. Borodic GE, Hinkle D. Ipilimumab-induced orbital inflammation resembling Graves disease with subsequent development of systemic hyperthyroidism from CTLA-4 receptor suppression. Ophthalmic Plast Reconstr Surg. 2014 Jan-Feb; 30(1):83. PMID: 24398505.
    Citations: 8     Fields:    Translation:Humans
  4. Borodic GE, Hinkle DM. Reply Re: "Drug-induced Graves disease from CTLA-4 receptor suppression". Ophthalmic Plast Reconstr Surg. 2013 May-Jun; 29(3):241. PMID: 23652295.
    Citations: 3     Fields:    Translation:Humans
  5. Borodic GE. Use of fillers as adjunct therapy for the treatment of lower face hemifacial spasm. Ophthalmic Plast Reconstr Surg. 2013 May-Jun; 29(3):225-6. PMID: 23559346.
    Citations: 1     Fields:    Translation:Humans
  6. Kirzhner M, Jakobiec FA, Borodic G. Desmoplastic trichoepithelioma: report of a unique periocular case. Ophthalmic Plast Reconstr Surg. 2012 Sep-Oct; 28(5):e121-3. PMID: 22366669.
    Citations:    Fields:    Translation:Humans
  7. Borodic G, Hinkle DM, Cia Y. Drug-induced graves disease from CTLA-4 receptor suppression. Ophthalmic Plast Reconstr Surg. 2011 Jul-Aug; 27(4):e87-8. PMID: 21242854.
    Citations: 32     Fields:    Translation:Humans
  8. Borodic GE. Functional significance of fat surrounding the orbicularis oculi muscle. Ophthalmic Plast Reconstr Surg. 2010 Nov-Dec; 26(6):501-2. PMID: 20724859.
    Citations:    Fields:    Translation:Humans
  9. Borodic GE. Orbicularis oculi myo-osseous fixation: a new treatment for benign essential blepharospasm and blepharospasm associated with diffuse facial dystonia (meige syndrome). Ophthalmic Surg Lasers Imaging. 2010 May-Jun; 41(3):360-9. PMID: 20507022.
    Citations: 1     Fields:    Translation:Humans
  10. Pellett S, Tepp WH, Clancy CM, Borodic GE, Johnson EA. A neuronal cell-based botulinum neurotoxin assay for highly sensitive and specific detection of neutralizing serum antibodies. FEBS Lett. 2007 Oct 16; 581(25):4803-8. PMID: 17889852; PMCID: PMC2748649.
    Citations: 46     Fields:    Translation:HumansAnimalsCells
  11. Borodic G. Botulinum toxin, immunologic considerations with long-term repeated use, with emphasis on cosmetic applications. Facial Plast Surg Clin North Am. 2007 Feb; 15(1):11-6, v. PMID: 17317551.
    Citations: 10     Fields:    Translation:Humans
  12. Borodic G. Immunologic resistance after repeated botulinum toxin type a injections for facial rhytides. Ophthalmic Plast Reconstr Surg. 2006 May-Jun; 22(3):239-40. PMID: 16714951.
    Citations: 14     Fields:    Translation:Humans
  13. Acquadro MA, Borodic GE. Botulinum toxin efficacy for the treatment of pain. J Clin Anesth. 2005 Aug; 17(5):328-30. PMID: 16102679.
    Citations:    Fields:    Translation:Humans
  14. Borodic G, Bartley M, Slattery W, Glasscock M, Johnson E, Malazio C, Goodnough M, Acquadro M, McKenna M. Botulinum toxin for aberrant facial nerve regeneration: double-blind, placebo-controlled trial using subjective endpoints. Plast Reconstr Surg. 2005 Jul; 116(1):36-43. PMID: 15988245.
    Citations: 11     Fields:    Translation:HumansCTClinical Trials
  15. Borodic GE, Acquadro MA. The use of botulinum toxin for the treatment of chronic facial pain. J Pain. 2002 Feb; 3(1):21-7. PMID: 14622850.
    Citations: 22     Fields:    
  16. Borodic GE, Acquadro M, Johnson EA. Botulinum toxin therapy for pain and inflammatory disorders: mechanisms and therapeutic effects. Expert Opin Investig Drugs. 2001 Aug; 10(8):1531-44. PMID: 11772268.
    Citations: 27     Fields:    Translation:HumansAnimals
  17. Tarsy D, Bhattacharyya N, Borodic G. Myasthenia gravis after botulinum toxin A for Meige syndrome. Mov Disord. 2000 Jul; 15(4):736-8. PMID: 10928589.
    Citations: 6     Fields:    Translation:Humans
  18. Troll G, Borodic G. Diplopia after cataract surgery using 4% lidocaine in the absence of Wydase (sodium hyaluronidase) J Clin Anesth. 1999 Nov; 11(7):615-6. PMID: 10624651.
    Citations:    Fields:    Translation:HumansCells
  19. Hayashi N, Borodic G, Karesh JW, Tolentino MJ, Remulla HD, Van Wesep RA, Grossniklaus HE, Jakobiec FA, Green WR. Giant cell angiofibroma of the orbit and eyelid. Ophthalmology. 1999 Jun; 106(6):1223-9. PMID: 10366097.
    Citations: 6     Fields:    Translation:Humans
  20. Borodic G. Myasthenic crisis after botulinum toxin. Lancet. 1998 Dec 05; 352(9143):1832. PMID: 9851395.
    Citations: 5     Fields:    Translation:Humans
  21. Pardo FS, Borodic G. Long-term follow-up of patients undergoing definitive radiation therapy for sebaceous carcinoma of the ocular adnexae. Int J Radiat Oncol Biol Phys. 1996 Mar 15; 34(5):1189-90. PMID: 8600110.
    Citations:    Fields:    Translation:Humans
  22. Borodic G, Johnson E, Goodnough M, Schantz E. Botulinum toxin therapy, immunologic resistance, and problems with available materials. Neurology. 1996 Jan; 46(1):26-9. PMID: 8559392.
    Citations: 24     Fields:    Translation:Humans
  23. Pearce LB, First ER, Borodic GE. Botulinum toxin: death versus localized denervation. J R Soc Med. 1995 Apr; 88(4):239-40. PMID: 7745582.
    Citations:    Fields:    
  24. Pearce LB, Borodic GE, Johnson EA, First ER, MacCallum R. The median paralysis unit: a more pharmacologically relevant unit of biologic activity for botulinum toxin. Toxicon. 1995 Feb; 33(2):217-27. PMID: 7597725.
    Citations: 7     Fields:    Translation:Animals
  25. Borodic GE, Duane D, Pearce B, Johnson E. Antibodies to botulinum toxin. Neurology. 1995 Jan; 45(1):204. PMID: 7880304.
    Citations: 2     Fields:    Translation:HumansAnimalsPHPublic Health
  26. Borodic G. Therapeutic botulinum toxin. Lancet. 1994 Nov 12; 344(8933):1370. PMID: 7968058.
    Citations: 2     Fields:    Translation:Humans
  27. Pearce LB, First ER, Borodic GE. Botulinum toxin potency: a mystery resolved by the median paralysis. J R Soc Med. 1994 Sep; 87(9):571-2. PMID: 7932477.
    Citations: 2     Fields:    Translation:Humans
  28. Pearce LB, Borodic GE, First ER, MacCallum RD. Measurement of botulinum toxin activity: evaluation of the lethality assay. Toxicol Appl Pharmacol. 1994 Sep; 128(1):69-77. PMID: 8079356.
    Citations: 27     Fields:    Translation:Animals
  29. Borodic GE, Pearce LB. New concepts in botulinum toxin therapy. Drug Saf. 1994 Sep; 11(3):145-52. PMID: 7811397.
    Citations:    Fields:    Translation:HumansAnimals
  30. Borodic G, Pearce LB, Johnson E. Antibodies to botulinum toxin. Ophthalmology. 1994 Jul; 101(7):1158-9. PMID: 8035973.
    Citations:    Fields:    Translation:Humans
  31. First ER, Pearce LB, Borodic GE. Dose standardisation of botulinum toxin. Lancet. 1994 Apr 23; 343(8904):1035. PMID: 7909062.
    Citations: 3     Fields:    Translation:Animals
  32. Acquadro MA, Borodic GE. Treatment of myofascial pain with botulinum A toxin. Anesthesiology. 1994 Mar; 80(3):705-6. PMID: 8141474.
    Citations: 14     Fields:    Translation:Humans
  33. Borodic GE, Ferrante R, Pearce LB, Smith K. Histologic assessment of dose-related diffusion and muscle fiber response after therapeutic botulinum A toxin injections. Mov Disord. 1994 Jan; 9(1):31-9. PMID: 8139603.
    Citations: 49     Fields:    Translation:AnimalsCells
  34. Borodic GE, Pearce LB, Cheney M, Metson R, Brownstone D, Townsend D, McKenna M. Botulinum A toxin for treatment of aberrant facial nerve regeneration. Plast Reconstr Surg. 1993 May; 91(6):1042-5. PMID: 8479969.
    Citations: 3     Fields:    Translation:Humans
  35. Borodic GE, Pearce LB, Smith KL, Phelan M, Ferrante R. Botulinum B toxin as an alternative to botulinum A toxin: a histologic study. Ophthalmic Plast Reconstr Surg. 1993; 9(3):182-90. PMID: 8217959.
    Citations: 3     Fields:    Translation:Animals
  36. Borodic GE, Cheney M, McKenna M. Contralateral injections of botulinum A toxin for the treatment of hemifacial spasm to achieve increased facial symmetry. Plast Reconstr Surg. 1992 Dec; 90(6):972-7; discussion 978-9. PMID: 1448532.
    Citations: 3     Fields:    Translation:Humans
  37. Borodic GE, Ferrante R. Effects of repeated botulinum toxin injections on orbicularis oculi muscle. J Clin Neuroophthalmol. 1992 Jun; 12(2):121-7. PMID: 1385821.
    Citations: 17     Fields:    Translation:HumansAnimals
  38. Borodic GE. Botulinum A toxin for (expressionistic) ptosis overcorrection after frontalis sling. Ophthalmic Plast Reconstr Surg. 1992; 8(2):137-42. PMID: 1520657.
    Citations: 3     Fields:    Translation:Humans
  39. Borodic GE, Pearce LB, Smith K, Joseph M. Botulinum a toxin for spasmodic torticollis: multiple vs single injection points per muscle. Head Neck. 1992 Jan-Feb; 14(1):33-7. PMID: 1624292.
    Citations: 13     Fields:    Translation:Humans
  40. Borodic GE, Ferrante R, Wiegner AW, Young RR. Treatment of spasticity with botulinum toxin. Ann Neurol. 1992 Jan; 31(1):113. PMID: 1543342.
    Citations: 1     Fields:    Translation:Humans
  41. Borodic GE, Mills L, Joseph M. Botulinum A toxin for the treatment of adult-onset spasmodic torticollis. Plast Reconstr Surg. 1991 Feb; 87(2):285-9. PMID: 1989021.
    Citations: 4     Fields:    Translation:Humans
  42. Borodic GE, Cozzolino D, Ferrante R, Wiegner AW, Young RR. Innervation zone of orbicularis oculi muscle and implications for botulinum A toxin therapy. Ophthalmic Plast Reconstr Surg. 1991; 7(1):54-60. PMID: 1708272.
    Citations: 6     Fields:    Translation:HumansCells
  43. Borodic GE, Joseph M, Fay L, Cozzolino D, Ferrante RJ. Botulinum A toxin for the treatment of spasmodic torticollis: dysphagia and regional toxin spread. Head Neck. 1990 Sep-Oct; 12(5):392-9. PMID: 2211099.
    Citations: 27     Fields:    Translation:HumansAnimalsCells
  44. Borodic GE, Cozzolino D. Blepharospasm and its treatment, with emphasis on the use of botulinum toxin. Plast Reconstr Surg. 1989 Mar; 83(3):546-54. PMID: 2645599.
    Citations: 7     Fields:    Translation:Humans
  45. Borodic GE, Townsend DJ, Beyer-Machule CK. Dermis fat graft in eviscerated sockets. Ophthalmic Plast Reconstr Surg. 1989; 5(2):144-9. PMID: 2487209.
    Citations: 1     Fields:    Translation:Humans
  46. Borodic GE, Beyer-Machule CK, Millin J, Conte J, Foster CS. Immunoglobulin deposition in localized conjunctival amyloidosis. Am J Ophthalmol. 1984 Nov; 98(5):617-22. PMID: 6496617.
    Citations: 4     Fields:    Translation:Humans
  47. Borodic GE, Gragoudas ES, Edward WO, Brockhurst RJ. Peripapillary subretinal neovascularization and serous macular detachment. Association with congenital optic nerve pits. Arch Ophthalmol. 1984 Feb; 102(2):229-31. PMID: 6199007.
    Citations:    Fields:    Translation:Humans
  48. Calderone JP, Chess J, Borodic G, Albert DM. Intraocular pathology of trisomy 18 (Edwards's syndrome): report of a case and review of the literature. Br J Ophthalmol. 1983 Mar; 67(3):162-9. PMID: 6824623.
    Citations: 7     Fields:    Translation:HumansCells
  49. Ashikaga T, Borodic G, Sims EA. Multiple daily insulin injections in the treatment of diabetic retinopathy. The Job study revisited. Diabetes. 1978 May; 27(5):592-6. PMID: 648750.
    Citations: 3     Fields:    Translation:Humans
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact contactcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Borodic's Networks
Click the
buttons for more information and interactive visualizations!
Concepts (197)
Co-Authors (8)
Similar People (60)
Same Department 
Physical Neighbors
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.